Last update :
27/01/2012
Newsletter :
Stability and compatibility of injectable drugs
Welcome in Stabilis. If you wish to receive the quarterly newsletter, indicate your email address.

If you have any questions or comments, please contact : stabilis@wanadoo.fr
Database  
References : 1440
Compounds : 391
Pharmacological Class : 39
Stability in mixtures : 821
Stability of solutions : 3419
Incompatibilities : 1945
Trade Name : 2002
News - Compounds  
Cytostatic Injection Nelarabine 11/09/2011
Glucose-lowering Injection Insulin lyspro 28/05/2011
Various Injection Trisodium citrate 28/05/2011
Analgesic Injection Piritramide 28/05/2011
Antimuscarinic Injection Scopolamine N-butyl bromide 10/04/2011
Various Injection Doxofylline 06/03/2011
Antibiotic Injection Polymyxine B 06/03/2011
Cytostatic Injection Panitumumab 19/12/2010
Cytostatic Injection Ofatumumab 19/12/2010
Cytostatic Injection Temozolomide 19/12/2010
Cytostatic Injection Decitabine 19/12/2010
Cytostatic Injection Vinflunine 19/12/2010
Antibiotic Injection Temocilline 19/12/2010
Cytostatic Injection Doxorubicin hydrochloride liposome 09/09/2010
Cytostatic Injection Cabazitaxel 05/09/2010
Cytostatic Injection Alemtuzumab 19/04/2010
Cytostatic Injection Clofarabine 16/04/2010
Cytostatic Injection Ixabepilone 16/04/2010
Cytostatic Injection Paclitaxel albumin 01/03/2010
Various Injection Eculizumab 01/03/2010
News - References  
Date of Entry
3246 Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C. SFPO Congress Mandelieu, France 18/11/2011
3240 Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène. Congrès SFPO 07/11/2011
3241 Physicochemical and biological stability of diluted rituximab solutions stored 6 months at 4°C. ECCO Congress Stockholm 07/11/2011
3243 Stability of diluted L-asparaginase in normal saline solution. ECCO Congress Stockholm 07/11/2011
3237 Jevtana® Résumé des caractéristiques du produit. Sanofi Aventis France 18/09/2011
3236 Vidaza® Résumé des caractéristiques du produit (France) Celgene 09/09/2011
3228 Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers Am J Health-Syst Pharm 05/09/2011
3229 Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes Am J Health-Syst Pharm 05/09/2011
3230 Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags Can J Hosp Pharm 05/09/2011
3231 Stability of Ciprofloxacin in Polyvinylchloride Minibags. Can J Hosp Pharm 05/09/2011
3235 Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen. ADKA Congress 2011 05/09/2011
3224 The stability of soluble insulin in plastic syringes EJHP Science 17/08/2011
3222 Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags Am J Health-Syst Pharm 12/08/2011
3223 Stability of diluted adenosine solutions in polyvinyl chloride infusion bags Am J Health-Syst Pharm 12/08/2011
3220 Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes. Can J Hosp Pharm 02/08/2011
3212 Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Enferm Intensiva 22/06/2011
3214 Stability of vincristine (TEVA) in original vials after re-use in dilute infusions in polyolefin bags and in polypropylene syringes. EJOP 22/06/2011
3215 Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. EJOP 22/06/2011
3216 Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel 22/06/2011
3208 Stability of Ertapenem in an Elastomeric Infusion Device. Int J Pharm Compound 21/05/2011
3209 Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles. Int J Pharm Compound 21/05/2011
3210 Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations. Int J Pharm Compound 21/05/2011
3204 Stability of Azacitidine Suspensions. Ann Pharmacotherapy 20/05/2011
3198 Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas. Farm Hosp 18/04/2011
3195 Physical and chemical stability of docetaxel infusions. EJHP 08/04/2011
3193 Stability of 25 mg/ml azacitidine suspensions stored in polypropylene syringes at -20°C. EAHP Congress, Vienna, Austria. 02/04/2011
3188 Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions. J Clin Pharm Ther 15/03/2011
3189 Stability of intravenous flucloxacillin solutions used for hospital-in-the-home. J Pharm Pract and Res 15/03/2011
3190 An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Advance in Haematology 15/03/2011
3184 Hyalase (hyaluronidase) Summury of Product characteristics. CP Pharmaceuticals 15/02/2011

Site créé par Cyril Labbé - Temps de calcul serveur : 59 millisecondes